Track CMPS and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Compass Pathways Plc
33 Broadwick Street, London, United Kingdom, W1F 0DQ
IPO
2020
Employees
156
Industry
Medical Care Facilities
Sector
Healthcare
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
Insider Transactions
Quarterly buy vs. sell activity
Sell (left)Buy (right)
Q3 20241-1
0
Q2 20243-3
0
Q1 20247-7
0
Q4 20231-1
0
4-quarter cumulative
12 sells0 buys
Analyst Ratings
4 analysts covering
Buy100%recommend buy
Buy
4
Hold
0
Sell
0